RPID vs. DTIL, HBIO, SEER, AKYA, BNGO, PRE, AXDX, OMIC, TLIS, and ASTC
Should you be buying Rapid Micro Biosystems stock or one of its competitors? The main competitors of Rapid Micro Biosystems include Precision BioSciences (DTIL), Harvard Bioscience (HBIO), Seer (SEER), Akoya Biosciences (AKYA), Bionano Genomics (BNGO), Prenetics Global (PRE), Accelerate Diagnostics (AXDX), Singular Genomics Systems (OMIC), Talis Biomedical (TLIS), and Astrotech (ASTC).
Precision BioSciences (NASDAQ:DTIL) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation, community ranking and dividends.
Precision BioSciences received 84 more outperform votes than Rapid Micro Biosystems when rated by MarketBeat users. Likewise, 67.18% of users gave Precision BioSciences an outperform vote while only 26.67% of users gave Rapid Micro Biosystems an outperform vote.
Rapid Micro Biosystems has lower revenue, but higher earnings than Precision BioSciences. Precision BioSciences is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.
38.0% of Precision BioSciences shares are held by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are held by institutional investors. 4.0% of Precision BioSciences shares are held by company insiders. Comparatively, 30.4% of Rapid Micro Biosystems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Precision BioSciences has a beta of 1.62, suggesting that its share price is 62% more volatile than the S&P 500. Comparatively, Rapid Micro Biosystems has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500.
Precision BioSciences currently has a consensus price target of $46.33, suggesting a potential upside of 264.54%. Given Rapid Micro Biosystems' higher probable upside, equities analysts clearly believe Precision BioSciences is more favorable than Rapid Micro Biosystems.
Precision BioSciences has a net margin of -48.10% compared to Precision BioSciences' net margin of -224.73%. Precision BioSciences' return on equity of -42.25% beat Rapid Micro Biosystems' return on equity.
In the previous week, Precision BioSciences had 2 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 4 mentions for Precision BioSciences and 2 mentions for Rapid Micro Biosystems. Precision BioSciences' average media sentiment score of 1.88 beat Rapid Micro Biosystems' score of 1.38 indicating that Rapid Micro Biosystems is being referred to more favorably in the news media.
Summary
Precision BioSciences beats Rapid Micro Biosystems on 10 of the 17 factors compared between the two stocks.
Get Rapid Micro Biosystems News Delivered to You Automatically
Sign up to receive the latest news and ratings for RPID and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RPID and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Rapid Micro Biosystems Competitors List
Related Companies and Tools
